glp-1 and rheumatoid arthritis Glucagon-Like Peptide-1 (GLP-1) receptor agonists in rheumatology: A review of current evidence future directions GLP-1 agonists' potential effects on
Description
The fundamental issue is that the skin barrier prevents the absorption of weight loss compounds at levels that could meaningfully affect appetite or metabolism
Ethics Approval Not applicable
Many notice appetite suppression within the first 1 to 4 weeks
Thorkildsen C, Neve S, Larsen BD, Meier E, Petersen JS
However, discontinuing the drugs can often lead to rebound weight gain or the worsening of metabolic health
